New Board Member For Jounce Therapeutics
Cancer immunotherapy company Jounce Therapeutics Inc. has appointed Barbara G. Duncan to its board of directors. Duncan has spent the last seven years at Intercept Pharmaceuticals Inc., where she was chief financial officer and treasurer. Prior to this, she held a number of leadership roles at DOV Pharmaceutical Inc., including chief executive officer. Duncan currently also serves on the boards of Edgemont Pharmaceuticals, LLC., Medgenics Inc. and Adaptimmune.
Register for our free email digests: